$0.000001
At close: Nov 19, 2:15 PM EDT
Comments
Loading...
Canntab Therapeutics (OTC:CTABF) Stock, Earnings Estimates, EPS, And Revenue
Canntab Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
EPS
–
Quarterly Revenue
–
Annual Revenue
(as of Feb 28)
(as of Feb 28)
$73.48 K
Analyze the earnings history of Canntab Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Canntab Therapeutics (CTABF) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Canntab Therapeutics (CTABF) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Canntab Therapeutics (OTCEM:CTABF) reporting earnings?
There are no earnings for Canntab Therapeutics
What were the latest earnings per share (EPS) for Canntab Therapeutics (OTCEM:CTABF)?
There are no earnings for Canntab Therapeutics
What were Canntab Therapeutics’s (OTCEM:CTABF) revenues?
There are no earnings for Canntab Therapeutics
Browse earnings estimates, EPS, and revenue on all stocks.